Hong Kong United Oncology Centre Jordan

Site:	Hong Kong United Oncology Centre Jordan
Address:
City:	Hong Kong
State:
Zip:
Country:	China

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors	Recruiting	Active, not recruiting	Bezuclastinib plus Sunitinib	NCT05208047